GoIndustry DoveBid appoints SVP of North American sales

Romie Castelli returns to the company he originally joined in 2002

GoIndustry DoveBid, a provider of asset management services for industrial companies, has appointed Romie Castelli as senior vice president of North American sales.

Castelli takes responsibility for directing GoIndustry DoveBid’s sales and marketing efforts in North America. He was most recently senior vice president of corporate services at Great American Group. Before that, as senior vice president of North America at DoveBid, prior to its acquisition by GoIndustry in 2008, he was responsible for the DoveBid sales force.

Castelli joined DoveBid in 2002 through acquisition, having been vice president of sales for ZoneTrader.

You may also like

Finance

Berry Global invests to increase production capacity for healthcare products

Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites
Research & Development

Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates

The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Manufacturing

Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities

Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Research & Development

SNIPR Biome receives funding to progress CRISPR medicine SNIPR001 into clinical trials

Phase 1b/2a trial will evaluate SNIPR001 for the prevention of E.coli infections in patients undergoing hematopoietic stem cell transplantation
Research & Development

SeaBeLife awarded over €1.5 million in i-Nov innovation competition

Funding for company’s SeaBeEYE project will be used to develop a new therapeutic approach for geographic atrophy, a form of age-related macular degeneration
Drug Delivery

Adult vaccination programmes deliver significant socio-economic benefits, study finds

The study shows that adult immunisation programmes return 19x their initial investment, which could ease the pressure on health systems
Regulatory

Policy vacuum risks UK becoming a medicines supply backwater

The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Subscribe now